BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19461006)

  • 1. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.
    Bowden RG; Wilson RL; Deike E; Gentile M
    Nutr Clin Pract; 2009; 24(4):508-12. PubMed ID: 19461006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
    Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
    Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T; Schmidt EB; Christensen JH
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
    Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
    Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
    Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
    Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
    Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
    Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA
    J Ren Nutr; 2012 Nov; 22(6):572-7. PubMed ID: 22285316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
    J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Cerchietti LC; Navigante AH; Castro MA
    Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
    Bowden RG; Jitomir J; Wilson RL; Gentile M
    J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
    Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
    J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of over-the-counter fish-oil administration on plasma Lp(a) levels in an end-stage renal disease population.
    Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
    J Ren Nutr; 2009 Nov; 19(6):443-9. PubMed ID: 19748798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension.
    Landmark K; Thaulow E; Hysing J; Mundal HH; Eritsland J; Hjermann I
    J Hum Hypertens; 1993 Feb; 7(1):25-32. PubMed ID: 8450517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state.
    Jellema A; Plat J; Mensink RP
    Eur J Clin Invest; 2004 Nov; 34(11):766-73. PubMed ID: 15530150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
    Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
    Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
    Agren JJ; Hänninen O; Julkunen A; Fogelholm L; Vidgren H; Schwab U; Pynnönen O; Uusitupa M
    Eur J Clin Nutr; 1996 Nov; 50(11):765-71. PubMed ID: 8933125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.